Core Laboratories Inc.
$7.76-$0.64 (-7.6%)
Last close · Data as of Nov 20, 2026
- Market cap
- $629.7M
- P/E
- 21.2x
- EV / EBITDA
- 10.8x
- Revenue
- $526.5M
- Net margin
- 5.6%
- ROCE
- 10.6%
Price chart
Technical chartScreen technicals →-44.1% over the last year
Daily closes.
Go deeper
Technical chart: candles, 28 indicators including moving averages, RSI and MACD, drawing tools and five colour themes
Performance
Price return, before dividends, to the 20 Nov 2026 close.
- 1M
- -22.9%
- 3M
- -36.9%
- 6M
- -43.6%
- 1Y
- -44.1%
- 5Y
- -68.2%
52-week range
Day change -$0.64 (-7.6%) from $8 to $8 · Last close Nov 20, 2026
Best weekday to invest, historically
The same weekly amount in CLB, bought on each weekday since 2021.
News & filings
What Core Laboratories filed, who traded, and what's next
How to read this
"News & filings" lists what the company itself has put on record with regulators, who inside it traded, the news that names it, and the next date we know of. Filings and releases are first-hand; news is third-party and may be thin for smaller companies. A day of insider filings is one row. Nothing here is a recommendation.
AI Summary
US StockConcernThe price is 40.7% below its 200-day average, and the 50-day average is below the 200-day.
Strengths (1)
- Operating profit was 5.3 times interest costs.
Prices to the 20 Nov 2026 close · Financial year: fiscal 2025
Rule-based from financial data. Not advice.
About the company
Core Laboratories Inc. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments.
Read moreShow less
Core Laboratories Inc. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and natural gas from its clients' reservoirs. It offers laboratory-based analytical and field services to characterize properties of crude oil and oil delivered products; and proprietary and joint industry studies, as well as services that support carbon capture, utilization and storage, geothermal projects, and the evaluation and appraisal of mining activities. The Production Enhancement segment provides services and products relating to reservoir well completions, perforations, stimulations, production, and well abandonment. It offers integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions to improve the effectiveness of enhanced oil recovery projects. The company markets and sells its products through a combination of sales representatives, technical seminars, trade shows, and print advertising, as well as through distributors. Core Laboratories Inc. was founded in 1936 and is based in Houston, Texas.
- Sector
- Energy
- Shares outstanding
- 43.0M
Key statistics
Screen fundamentals →Valuation, profitability, growth and solvency at the latest close; hover a label for its meaning.
Valuation
- Market cap
- $629.7M
- P/E
- 21.2x
- P/B
- 2.4x
- EV / EBITDA
- 10.8x
- EV / Sales
- 1.5x
- P/S
- 1.2x
- 52-week high
- $19.67
- 52-week low
- $7.76
Profitability
- Operating margin
- 9.6%
- Net margin
- 5.6%
- EBITDA margin
- 13.5%
- ROE
- 11.2%
- ROCE
- 10.6%
- ROA
- 5.1%
- Asset turnover
- 0.90
Growth
- RevenueFY2025, the latest fiscal year in the company's growth history.
- $526.5M
- Revenue growth, 1YFY2025, the latest fiscal year in the company's growth history.
- 0.5%
- Revenue CAGR, 3YFY2025, the latest fiscal year in the company's growth history.
- 2.4%
- Net profit growth, 1YFY2025, the latest fiscal year in the company's growth history.
- -5.5%
- Free cash flowFY2025, the latest fiscal year in the company's growth history.
- $22.3M
Solvency
- Current ratio
- 2.02
- Debt / Equity
- 0.62
- Debt / Assets
- 0.28
- CFO / Net profit
- 1.25
- Cash / Market cap
- 3.6%
Where the revenue went
Of every $100 of FY2025 revenue, $6 was left as net income.
| From | To | Amount |
|---|---|---|
| Revenue | Cost of revenue | $432.2M |
| Revenue | Gross profit | $94.3M |
| Gross profit | Operating expenses | $43.8M |
| Gross profit | Operating income | $50.5M |
| Operating income | Pretax income | $45.9M |
| Operating income | Interest and other expense | $4.6M |
| Pretax income | Tax and other | $16.2M |
| Pretax income | Net income | $29.7M |
Revenue and net profit
Revenue grew 0.5% in FY2025; net profit is the dashed line.
| Date | Revenue | Net profit |
|---|---|---|
| FY2022 | $489.7M | $19.5M |
| FY2023 | $509.8M | $36.7M |
| FY2024 | $523.8M | $31.4M |
| FY2025 | $526.5M | $29.7M |
Cash flows
FY2025: $37.0M from operations, $22.3M free after investment (dashed).
| Date | Operating cash flow | Free cash flow |
|---|---|---|
| FY2022 | $25.0M | $14.7M |
| FY2023 | $24.8M | $14.2M |
| FY2024 | $56.4M | $43.4M |
| FY2025 | $37.0M | $22.3M |
Growth
Latest fiscal year 2025: each figure with its change over the year before.
- Revenue
- $526.5M+0.5%1Y
- EBITDA
- $71.1M-3.3%1Y
- Net profit
- $29.7M-5.5%1Y
- Cash from operations
- $37.0M-34.3%1Y
- Free cash flow
- $22.3M-48.6%1Y
- Revenue CAGR, 3Y
- 2.4%
- Net profit CAGR, 3Y
- 15.1%
| Year | Revenue | EBITDA | Net profit | FCF | ROE | Revenue growth 1Y | Net profit growth 1Y |
|---|---|---|---|---|---|---|---|
| FY2025 | $526.5M | $71.1M | $29.7M | $22.3M | 11.2% | +0.5% | -5.5% |
Monthly returns
Month-by-month returns of CLB across the years, with the seasonal pattern.
Balance sheet
What the company owns and owes at the end of FY2025.
| Line | FY2025 |
|---|---|
| Assets | $584.0M |
| Current assets | $214.7M |
| Non-current assets | $369.3M |
| Liabilities | $311.8M |
| Current liabilities | $106.0M |
| Non-current liabilities | $205.8M |
| Equity | $272.2M |
| Paid-in capital | $110.2M |
| Retained earnings | $172.7M |
| Treasury stock | $11.6M |
| Minority interest | $6.2M |
Market cap against peers
8 peers: same sector, nearest by size.
Peers map
Energy companies placed by value, growth and quality; CLB highlighted.
P/E against peers
CLB trades at 21.2x earnings against a peer median of 8.2x (a 158% premium).
Not shown (no positive earnings and no EV / Sales): W&T Offshore, Inc., Forum Energy Technologies, Inc., VAALCO Energy, Inc., Oil States International, Inc.
Peer comparison
Same-sector peers by market cap, with the median.
| Company | Market cap | P/E | P/B | ROE | EV/EBITDA |
|---|---|---|---|---|---|
| Core Laboratories Inc.CLBthis companyP/E ↑ premium | $629.7M | 21.2x | 2.4x | 11.2% | 10.8x |
| Vitesse Energy, Inc.VTS | $742.9M | 29.4x | 1.2x | 4.0% | 5.0x |
| Granite Ridge Resources, Inc.GRNT | $658.2M | 27.0x | 1.1x | 4.0% | 3.8x |
| W&T Offshore, Inc.WTI | $610.0M | -4.1x | -3.1x | 75.1% | 9.6x |
| Forum Energy Technologies, Inc.FET | $606.4M | -62.8x | 2.1x | -3.3% | 11.5x |
| VAALCO Energy, Inc.EGY | $600.3M | -14.5x | 1.4x | -9.3% | 7.5x |
| SandRidge Energy, Inc.SD | $577.8M | 8.2x | 1.1x | 13.7% | 4.3x |
| Oil States International, Inc.OIS | $523.1M | — | 0.9x | -19.1% | — |
| Natural Gas Services Group, Inc.NGS | $521.1M | 26.1x | 1.9x | 7.3% | 9.9x |
| Peer median | — | 8.2x | 1.2x | 4.0% | 7.5x |
Year-to-date ROI
CLB since 1 January, against earlier years.
Historical volatility
CLB's day-to-day swings over 30, 60 and 180 days.
Financial statements
Income statement, balance sheet and cash flow as reported, grouped into plain-language lines.
Consolidated figures in USD, fiscal years, newest first.
Operating margin by fiscal year
| Date | Operating margin |
|---|---|
| FY2022 | 8.4% |
| FY2023 | 11.0% |
| FY2024 | 9.5% |
| FY2025 | 9.6% |
| Line | FY2025 |
|---|---|
| RevenueTotal Revenue | $526.5M |
| Cost of revenueCost Of Revenue | $432.2M |
| Gross profitGross Profit | $94.3M |
| Operating expensesOperating Expense | $43.8M |
| Selling, general and administrativeSelling General And Administration | $44.2M |
| Provision for doubtful accountsProvision For Doubtful Accounts | -$430.0k |
| Total expensesTotal Expenses | $476.0M |
| Operating incomeOperating Income | $50.5M |
| Interest and other | |
| Pretax incomePretax Income | $45.9M |
| TaxTax Provision | $15.5M |
| Net incomeNet Income | $29.7M |
| Per share | |
| Supplementary |
| Line | FY2025 |
|---|---|
| AssetsTotal Assets | $584.0M |
| Current assetsCurrent Assets | $214.7M |
| Non-current assetsTotal Non Current Assets | $369.3M |
| LiabilitiesTotal Liabilities Net Minority Interest | $311.8M |
| Current liabilitiesCurrent Liabilities | $106.0M |
| Non-current liabilitiesTotal Non Current Liabilities Net Minority Interest | $205.8M |
| EquityTotal Equity Gross Minority Interest | $272.2M |
| Supplementary |
| Line | FY2025 |
|---|---|
| Operating cash flowOperating Cash Flow | $37.0M |
| Cash from continuing operationsCash Flow From Continuing Operating Activities | $37.0M |
| Net income, continuing operationsNet Income From Continuing Operations | $30.4M |
| Depreciation and amortisationDepreciation And Amortization | $14.7M |
| Depreciation, amortisation and depletionDepreciation Amortization Depletion | $14.7M |
| Depreciation | $14.3M |
| Amortization cash flowAmortization Cash Flow | $360.0k |
| Amortization of intangiblesAmortization Of Intangibles | $360.0k |
| Stock-based compensationStock Based Compensation | $7.1M |
| Deferred taxDeferred Tax | $1.4M |
| Deferred income taxDeferred Income Tax | $1.4M |
| Operating gains and lossesOperating Gains Losses | $340.0k |
| Gain loss on sale of businessGain Loss On Sale Of Business | — |
| Asset impairmentAsset Impairment Charge | $2.3M |
| Provision and write off of assetsProvisionand Write Offof Assets | $3.4M |
| Pension and employee benefit expensePension And Employee Benefit Expense | $340.0k |
| Change in working capitalChange In Working Capital | -$14.5M |
| Other non-cash itemsOther Non Cash Items | -$8.1M |
| Investing cash flowInvesting Cash Flow | -$2.2M |
| Cash from continuing investingCash Flow From Continuing Investing Activities | -$2.2M |
| Capital expenditureCapital Expenditure | -$14.7M |
| Capital expenditure (reported)Capital Expenditure Reported | -$14.6M |
| AcquisitionsPurchase Of Business | -$1.2M |
| DisposalsSale Of Business | — |
| Net acquisitions and disposalsNet Business Purchase And Sale | -$1.2M |
| Sale of investmentsSale Of Investment | — |
| Net investment purchases and salesNet Investment Purchase And Sale | — |
| Purchase of intangiblesPurchase Of Intangibles | — |
| Net intangibles purchases and salesNet Intangibles Purchase And Sale | -$150.0k |
| Dividends received (investing)Dividends Received Cfi | — |
| Other investing changesNet Other Investing Changes | $13.7M |
| Cash from discontinued investing activitiesCash From Discontinued Investing Activities | — |
| Financing cash flowFinancing Cash Flow | -$31.3M |
| Cash from continuing financingCash Flow From Continuing Financing Activities | -$31.3M |
| Debt issuedIssuance Of Debt | $48.0M |
| Debt repaidRepayment Of Debt | -$63.0M |
| Net debt issuedNet Issuance Payments Of Debt | -$15.0M |
| Long-term debt issuedLong Term Debt Issuance | $48.0M |
| Long-term debt repaidLong Term Debt Payments | -$63.0M |
| Net long-term debt issuedNet Long Term Debt Issuance | -$15.0M |
| Shares issuedIssuance Of Capital Stock | — |
| Common stock issuedCommon Stock Issuance | — |
| Net common stock issuedNet Common Stock Issuance | -$12.4M |
| Common stock repurchasedCommon Stock Payments | -$12.4M |
| Share buybacksRepurchase Of Capital Stock | -$12.4M |
| Dividends paidCash Dividends Paid | -$1.9M |
| Common dividends paidCommon Stock Dividend Paid | -$1.9M |
| Other financing chargesNet Other Financing Charges | -$2.0M |
| Change in cashChanges In Cash | $3.5M |
| Cash at the start of the yearBeginning Cash Position | $19.2M |
| Cash at the end of the yearEnd Cash Position | $22.7M |
| Free cash flowFree Cash Flow | $22.3M |
| Supplemental |
Learn while you research
Academy chapters picked for Core Laboratories Inc. and the metrics on this page.
- 01 Stock Valuation BasicsHow to think about what a fair price for a stock looks like.7 min read
- 02 Stock Market RisksSmall caps carry concentrated, idiosyncratic risk, learn to manage it.6 min read
- 03 Business Cycles & StocksThese cyclical sectors win and lose in different macro phases.6 min read
- 04 Essential Stock RatiosP/E, P/B, EV/EBITDA, what they mean and when to use each.7 min read
- 05 How to Read a Cash-Flow StatementProfit can be manipulated; cash flow rarely lies.7 min read